Injectable Drug Delivery Conference

Injectable Drug Delivery is an industry focused on two overarching topics - the development of the device & the interaction between drug product and device. SAE’s 2024 Injectable Drug Delivery conference brings together a complete big pharma speaker line-up providing technical updates on the relationship between drug product formulation and the device primary packaging, with considerations for formulation strategies, extractables & leachables and toxicological testing of injectable devices.

TÜV SÜD’s Senior Product Specialist, Estefania Dos Anjos, is speaking on 8th May at the event on the topic 'Notified Bodies’ Perspectives: Injectable Device Development'. The presentation will cover the following topics:

Outlining key primary packaging requirements
What is needed for a successful submission and NB opinion?
How industry can work more closely with regulators and notified bodies in implementation of new regulations
Challenges in life cycle management of combination products

Estefania Dos Anjos

Senior Product Specialist

Estefania Dos Anjos is a Senior Product Specialist in TÜV SÜD, with expertise as Technical Documentation Assessor for substance based and other Non Active Medical Devices. She is a Medicinal Product Specialist for Drug-Device Combination Devices and Product Reviewer for Article 117 devices under the EU Medical Device Regulation (2017/745). A Pharmacist with 10 years' experience in Regulatory Affairs of medical devices, pharmaceuticals, and cosmetic products in Latin America and Europe, Quality Management Systems under ISO 13485 and Good Manufacturing Practices.